Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice.

AUTOR(ES)

Aird, W C

RESUMO

The present study was undertaken to define the 5' and 3' regulatory sequences of human von Willebrand factor gene that confer tissue-specific expression in vivo. Transgenic mice were generated bearing a chimeric construct that included 487 bp of 5' flanking sequence and the first exon fused in-frame to the Escherichia coli lacZ gene. In situ histochemical analyses in independent lines demonstrated that the von Willebrand factor promoter targeted expression of LacZ to a subpopulation of endothelial cells in the yolk sac and adult brain. LacZ activity was absent in the vascular beds of the spleen, lung, liver, kidney, testes, heart, and aorta, as well as in megakaryocytes. In contrast, in mice containing the lacZ gene targeted to the thrombomodulin locus, the 5-bromo-4-chloro-3-indolyl beta-D-galactopyranoside reaction product was detected throughout the vascular tree. These data highlight the existence of regional differences in endothelial cell gene regulation and suggest that the 733-bp von Willebrand factor promoter may be useful as a molecular marker to investigate endothelial cell diversity.

Documentos Relacionados

• Endothelial-cell-specific regulation of von Willebrand factor gene expression.
• Synthesis of von Willebrand Factor by Cultured Human Endothelial Cells
• Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.
• Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice.
• Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex.